search
Back to results

A New Treatment for Zenker's Diverticulum-submucosal Tunneling Endoscopic Septum Division (STESD)

Primary Purpose

Zenker Diverticulum

Status
Unknown status
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Submucosal tunneling endoscopic septum division
Sponsored by
Shanghai Zhongshan Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Zenker Diverticulum focused on measuring Endoscopy, Digestive system, Natural orifice transluminal endoscopic surgery, Therapeutic, Complications

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of Zenker's diverticulum by symptoms, esophagram and/ or EGD
  • Symptomatic score≥2 in any of the symptoms or ≥3 in total
  • Patients or legal surrogates willing and competent to give informed consent and to comply with follow up visits and tests

Exclusion Criteria:

  • Patients with minimal symptoms (score ≤1 in all four symptoms and <3 in total)
  • Presence of coagulopathy or pregnancy
  • Patients who, in the investigator's opinion, are medically unstable or have a life expectancy of< 2 years, are unable to give informed consent or have poor compliance with follow-up, or whose risks of participating in the study outweigh the benefits

Sites / Locations

  • NYU Winthrop HospitalRecruiting
  • Zhongshan Hospital, Fudan UniversityRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

STESD

Arm Description

Submucosal tunneling endoscopic septum division

Outcomes

Primary Outcome Measures

Short-term change of symptom score
Symptoms for Zenker's diverticulum are scored at follow-up visits and compared with pre-STESD value
Peri-operative adverse events
Details and grading for any adverse event as defined by the ASGE lexicon are recorded during the peri-operative period

Secondary Outcome Measures

Mid-term change of symptom score
Symptoms for Zenker's diverticulum are evaluated at follow-up visit and compared to pre-STESD value
Change of diverticulum size under EGD
ESD is done at follow-up visit and configuration of the diverticulum is compared to that pre-STESD
Change of diverticulum size under esophagram
Barium esophagram is done at follow-up visit and configuration of the diverticulum is compared to that pre-STESD
Call for other treatments, such as repeat myotomy
Call for any additional treatment for Zenker's diverticulum is recorded at follow-up visits

Full Information

First Posted
April 16, 2017
Last Updated
August 2, 2018
Sponsor
Shanghai Zhongshan Hospital
Collaborators
Winthrop University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03125733
Brief Title
A New Treatment for Zenker's Diverticulum-submucosal Tunneling Endoscopic Septum Division
Acronym
STESD
Official Title
A Prospective International Multicenter Study on the Efficacy and Safety of Submucosal Tunneling Endoscopic Septum Division (STESD) for the Treatment of Zenker's Diverticulum
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Unknown status
Study Start Date
July 1, 2017 (Actual)
Primary Completion Date
June 14, 2019 (Anticipated)
Study Completion Date
June 14, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Shanghai Zhongshan Hospital
Collaborators
Winthrop University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Zenker's Diverticulum (ZD) is a sac-like outpouching of the lining of the esophageal wall at the upper esophagus. It is a rare disease typically seen in the middle-aged and older adults. Common symptoms of the disease include difficulties in swallowing (dysphagia), food reflux (regurgitation), unpleasant breath smells (halitosis) and couch, choking and hoarseness etc. (respiratory complications). Pills lodging in the sac and thus unable to take effect is also a common and yet often overlooked problem. Traditional treatment for ZD included open resection done by head and neck surgeons and direct septum division done by ENT doctors. Septum division done by endoscopists is a new modality of treatment and so far has used the same approach as the ENT doctors-the wall between the sac and the normal esophageal lumen (the septum) is cut down directly so that food will not be held in the sac. A cutting-edge endoscopic treatment for ZD is now emerging. In this approach, what we call submucosal tunneling endoscopic septum division (STESD), the wall is not cut directly, but inside a tunnel created by lifting the wallpaper (the mucosa lining the esophageal wall). After the muscle septum is completely cut, the mucosa is then sealed by clips, restoring integrity of the esophageal lining. The advantage of STESD is twofold. First, the esophageal mucosa will be sealed after the operation, so that the chance of extravasation of luminal content with its relevant complications will be smaller. Second, under the protection of the tunnel, the endoscopist will be able to cut the septum completely down to its bottom, ensuring a more satisfactory symptom resolution. In short, our hypothesis is that treating Zenker's diverticulum by the tunneling endoscopic technique should be both safer and more effective than traditional methods.
Detailed Description
Patients with symptomatic Zenker's diverticulum are considered for STESD. The diagnosis is based on clinical presentation, barium swallow, EGD and a swallow test to rule out other possible disorders causing cervical dysphagia. A scoring system (Costamagna, GIE, 2016) is used to evaluate severity of the symptoms. Four symptoms are evaluated: 1) dysphagia, 2) regurgitation, 3) daytime respiratory symptoms and 4) nighttime respiratory symptoms. These are scored based on a solid food diet according to the symptom frequency calculated within 2 consecutive weeks: 0-never, 1-1day/ week, 2-2~4days/ week, 3-≥5 days/ week. Under EGD and barium swallow test, configuration of the diverticulum is documented in detail (Shou-Jiang Tang, Laryngoscope, 2008). Quality of life is assessed using the SF-36 form. The pre- and post-STESD symptom score, quality of life score, and diverticulum configuration are compared. Adverse events are recorded and graded according to the system suggested by the ASGE workshop (Cotton, GIE, 2010).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Zenker Diverticulum
Keywords
Endoscopy, Digestive system, Natural orifice transluminal endoscopic surgery, Therapeutic, Complications

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
STESD
Arm Type
Experimental
Arm Description
Submucosal tunneling endoscopic septum division
Intervention Type
Procedure
Intervention Name(s)
Submucosal tunneling endoscopic septum division
Intervention Description
STESD includes 4 steps: Mucosal incision: submucosal injection of normal saline-indigo carmine solution is performed 2-3cm proximal to the diverticular septum and a 1.5-2cm longitudinal mucosal incision is made using the endoscopic knife. Submucosal tunneling: a submucosal tunnel is created using the same technique as applied by Peroral Endoscopic Myotomy (POEM) at both sides of the septum until 1-2cm distal to the bottom of the diverticulum. Septum Division: cricopharyngeal myotomy is performed longitudinally along the mid-line of the septum and ends in the normal esophageal muscle. Mucosal Closure: the mucosa incision, as well as any accidental mucosotomy if present, is closed with hemostatic clips.
Primary Outcome Measure Information:
Title
Short-term change of symptom score
Description
Symptoms for Zenker's diverticulum are scored at follow-up visits and compared with pre-STESD value
Time Frame
1 months after STESD
Title
Peri-operative adverse events
Description
Details and grading for any adverse event as defined by the ASGE lexicon are recorded during the peri-operative period
Time Frame
start of STESD to 30 days post-op
Secondary Outcome Measure Information:
Title
Mid-term change of symptom score
Description
Symptoms for Zenker's diverticulum are evaluated at follow-up visit and compared to pre-STESD value
Time Frame
12 months after STESD
Title
Change of diverticulum size under EGD
Description
ESD is done at follow-up visit and configuration of the diverticulum is compared to that pre-STESD
Time Frame
1 months after STESD
Title
Change of diverticulum size under esophagram
Description
Barium esophagram is done at follow-up visit and configuration of the diverticulum is compared to that pre-STESD
Time Frame
1 months after STESD
Title
Call for other treatments, such as repeat myotomy
Description
Call for any additional treatment for Zenker's diverticulum is recorded at follow-up visits
Time Frame
12 months after STESD
Other Pre-specified Outcome Measures:
Title
Changes in quality of life score
Description
Patients' quality of life is recorded by using the SF-36 system
Time Frame
Baseline and 12 months after STESD

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of Zenker's diverticulum by symptoms, esophagram and/ or EGD Symptomatic score≥2 in any of the symptoms or ≥3 in total Patients or legal surrogates willing and competent to give informed consent and to comply with follow up visits and tests Exclusion Criteria: Patients with minimal symptoms (score ≤1 in all four symptoms and <3 in total) Presence of coagulopathy or pregnancy Patients who, in the investigator's opinion, are medically unstable or have a life expectancy of< 2 years, are unable to give informed consent or have poor compliance with follow-up, or whose risks of participating in the study outweigh the benefits
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Quan-Lin Li, MD
Phone
+86-021-64041990
Email
liquanlin321@126.com
First Name & Middle Initial & Last Name or Official Title & Degree
Xiao-Cen Zhang, MD
Phone
+86-15000448731
Email
xcezhang@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ping-Hong Zhou, MD,PhD
Organizational Affiliation
Zhongshan Hospital, Fudan University, Shanghai, China
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Stavros N Stavropoulos, MD
Organizational Affiliation
NYU Winthrop Hospital, Mineola, NY, USA
Official's Role
Study Director
Facility Information:
Facility Name
NYU Winthrop Hospital
City
Mineola
State/Province
New York
ZIP/Postal Code
11501
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maria Kollarus, RN
Phone
516-663-4652
Email
maria.kollarus@nyulangone.org
First Name & Middle Initial & Last Name & Degree
Wilmide Maignan
Phone
+1(516)663-4623
Email
WMaignan@nyuwinthrop.org
First Name & Middle Initial & Last Name & Degree
Stavros N Stavropoulos, MD
First Name & Middle Initial & Last Name & Degree
Rani Modayil, MD
Facility Name
Zhongshan Hospital, Fudan University
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200032
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Quan-Lin Li, MD
Phone
+85-021-64041990
Email
liquanlin321@126.com
First Name & Middle Initial & Last Name & Degree
Ping-Hong Zhou, MD, PhD
First Name & Middle Initial & Last Name & Degree
Quan-Lin Li, MD

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
26344886
Citation
Costamagna G, Iacopini F, Bizzotto A, Familiari P, Tringali A, Perri V, Bella A. Prognostic variables for the clinical success of flexible endoscopic septotomy of Zenker's diverticulum. Gastrointest Endosc. 2016 Apr;83(4):765-73. doi: 10.1016/j.gie.2015.08.044. Epub 2015 Sep 3.
Results Reference
background
PubMed Identifier
18401278
Citation
Tang SJ, Jazrawi SF, Chen E, Tang L, Myers LL. Flexible endoscopic clip-assisted Zenker's diverticulotomy: the first case series (with videos). Laryngoscope. 2008 Jul;118(7):1199-205. doi: 10.1097/MLG.0b013e31816e2eee.
Results Reference
background
PubMed Identifier
20189503
Citation
Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A Jr, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010 Mar;71(3):446-54. doi: 10.1016/j.gie.2009.10.027. No abstract available.
Results Reference
background
PubMed Identifier
12440629
Citation
Gutschow CA, Hamoir M, Rombaux P, Otte JB, Goncette L, Collard JM. Management of pharyngoesophageal (Zenker's) diverticulum: which technique? Ann Thorac Surg. 2002 Nov;74(5):1677-82; discussion 1682-3. doi: 10.1016/s0003-4975(02)03931-0.
Results Reference
background
PubMed Identifier
18197932
Citation
Ferreira LE, Simmons DT, Baron TH. Zenker's diverticula: pathophysiology, clinical presentation, and flexible endoscopic management. Dis Esophagus. 2008;21(1):1-8. doi: 10.1111/j.1442-2050.2007.00795.x.
Results Reference
background
PubMed Identifier
24055983
Citation
Law R, Katzka DA, Baron TH. Zenker's Diverticulum. Clin Gastroenterol Hepatol. 2014 Nov;12(11):1773-82; quiz e111-2. doi: 10.1016/j.cgh.2013.09.016. Epub 2013 Sep 18.
Results Reference
background
PubMed Identifier
27664512
Citation
Li QL, Chen WF, Zhang XC, Cai MY, Zhang YQ, Hu JW, He MJ, Yao LQ, Zhou PH, Xu MD. Submucosal Tunneling Endoscopic Septum Division: A Novel Technique for Treating Zenker's Diverticulum. Gastroenterology. 2016 Dec;151(6):1071-1074. doi: 10.1053/j.gastro.2016.08.064. Epub 2016 Sep 21. No abstract available.
Results Reference
background
PubMed Identifier
25249144
Citation
Vigneswaran Y, Tanaka R, Gitelis M, Carbray J, Ujiki MB. Quality of life assessment after peroral endoscopic myotomy. Surg Endosc. 2015 May;29(5):1198-202. doi: 10.1007/s00464-014-3793-2. Epub 2014 Sep 24.
Results Reference
background

Learn more about this trial

A New Treatment for Zenker's Diverticulum-submucosal Tunneling Endoscopic Septum Division

We'll reach out to this number within 24 hrs